Danny Vesprini

7.5k total citations · 2 hit papers
159 papers, 4.9k citations indexed

About

Danny Vesprini is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Surgery. According to data from OpenAlex, Danny Vesprini has authored 159 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Pulmonary and Respiratory Medicine, 56 papers in Radiation and 35 papers in Surgery. Recurrent topics in Danny Vesprini's work include Prostate Cancer Diagnosis and Treatment (69 papers), Prostate Cancer Treatment and Research (64 papers) and Advanced Radiotherapy Techniques (56 papers). Danny Vesprini is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (69 papers), Prostate Cancer Treatment and Research (64 papers) and Advanced Radiotherapy Techniques (56 papers). Danny Vesprini collaborates with scholars based in Canada, United States and United Kingdom. Danny Vesprini's co-authors include Andrew Loblaw, Laurence Klotz, Liying Zhang, Steven A. Narod, Alexandre Mamedov, Suneil Jain, Vibhuti Jethava, Stanley K. Liu, Perakaa Sethukavalan and Toshihiro Yamamoto and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Analytical Chemistry.

In The Last Decade

Danny Vesprini

154 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate Cancer

2014 824 citations Danny Vesprini, Liying Zhang et al. profile →
Prevalence and Penetrance of Germline BRCA1 and BRCA2 Mutations in a Population Series of 649 Women with Ovarian Cancer

2001 730 citations Danny Vesprini, Steven A. Narod et al. The American Journal of Human Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Danny Vesprini Canada	35	2.5k	1.0k	1.0k	998	865	159	4.9k
P. Romestaing France	32	973 0.4×	410 0.4×	1.8k 1.8×	1.1k 1.1×	373 0.4×	142	3.8k
Himu Lukka Canada	24	2.0k 0.8×	243 0.2×	1.1k 1.1×	1.3k 1.3×	144 0.2×	77	4.4k
Jacob Rotmensch United States	33	729 0.3×	752 0.7×	796 0.8×	422 0.4×	179 0.2×	132	4.5k
Maartje J. Hooning Netherlands	29	436 0.2×	535 0.5×	1.0k 1.0×	1.2k 1.2×	1.2k 1.3×	73	3.0k
Philippe Rouanet France	42	740 0.3×	678 0.7×	3.2k 3.2×	1.9k 1.9×	292 0.3×	177	6.0k
Stephen C.K. Law China	35	1.1k 0.5×	545 0.5×	1.6k 1.6×	378 0.4×	276 0.3×	63	4.8k
Lori J. Wirth United States	48	2.4k 0.9×	2.0k 1.9×	4.3k 4.3×	961 1.0×	1.1k 1.3×	260	9.9k
Eleanor Harris United States	32	836 0.3×	278 0.3×	1.2k 1.2×	2.3k 2.3×	425 0.5×	123	3.9k
D. Azria France	46	2.8k 1.1×	718 0.7×	3.4k 3.3×	1.7k 1.7×	191 0.2×	372	7.6k
Jan Tennvall Sweden	35	1.2k 0.5×	403 0.4×	1.4k 1.4×	250 0.3×	439 0.5×	130	4.9k

Countries citing papers authored by Danny Vesprini

Since Specialization

Citations

This map shows the geographic impact of Danny Vesprini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danny Vesprini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danny Vesprini more than expected).

Fields of papers citing papers by Danny Vesprini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danny Vesprini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danny Vesprini. The network helps show where Danny Vesprini may publish in the future.

Co-authorship network of co-authors of Danny Vesprini

This figure shows the co-authorship network connecting the top 25 collaborators of Danny Vesprini. A scholar is included among the top collaborators of Danny Vesprini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danny Vesprini. Danny Vesprini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chan, Adrian Wai, Anh Tuan Hoang, Hanbo Chen, et al.. (2024). Prospective Trial on the Impact of Weekly Cone Beam Computed Tomography-Guided Correction on Mean Heart Dose in Breast Cancer Breath-Hold Radiation Therapy. Advances in Radiation Oncology. 9(12). 101651–101651.

Ha, Annie, Amanda Khoo, Vladimir Ignatchenko, et al.. (2024). Comprehensive Prostate Fluid-Based Spectral Libraries for Enhanced Protein Detection in Urine. Journal of Proteome Research. 23(5). 1768–1778. 3 indexed citations

Barnes, Elizabeth, Hanbo Chen, Gregory J. Czarnota, et al.. (2024). Uncovering the armpit of SBRT: An institutional experience with stereotactic radiation of axillary metastases. Clinical and Translational Radiation Oncology. 45. 100730–100730. 1 indexed citations

Ong, Wee Loon, Melanie Davidson, Mark Ruschin, et al.. (2023). Urethra contouring on computed tomography urethrogram versus magnetic resonance imaging for stereotactic body radiotherapy in prostate cancer. Clinical and Translational Radiation Oncology. 45. 100722–100722. 2 indexed citations

Moore-Palhares, Daniel, Ling Ho, Lin Lü, et al.. (2023). Clinical implementation of magnetic resonance imaging simulation for radiation oncology planning: 5 year experience. Radiation Oncology. 18(1). 27–27. 19 indexed citations

Finch, Amy, Danny Vesprini, Raymond H. Kim, et al.. (2022). An appraisal of genetic testing for prostate cancer susceptibility. npj Precision Oncology. 6(1). 43–43. 5 indexed citations

Vesprini, Danny, et al.. (2022). The Effect of Age on Prostate Cancer Survival. Cancers. 14(17). 4149–4149. 27 indexed citations

Glicksman, Rachel, Patrick Cheung, Darby Erler, et al.. (2022). Stereotactic Body Radiotherapy for Renal Cell Carcinoma: Oncological and Renal Function Outcomes. Clinical Oncology. 35(1). 20–28. 12 indexed citations

Glicksman, Rachel, Andrew Loblaw, Gerard Morton, et al.. (2021). Elective pelvic nodal irradiation with a simultaneous hypofractionated integrated prostate boost for localized high risk prostate cancer: Long term results from a prospective clinical trial. Radiotherapy and Oncology. 163. 21–31. 12 indexed citations

10.

Olkhov‐Mitsel, Ekaterina, Anjelica Hodgson, Stanley K. Liu, et al.. (2020). Immune gene expression profiles in high-grade urothelial carcinoma of the bladder: a NanoString study. Journal of Clinical Pathology. 74(1). 53–57. 9 indexed citations

11.

Lam, Emily, Stephanie Chan, Irene Karam, et al.. (2020). Use of Adjuvant Breast Hypofractionation Radiation Treatment at a Cancer Center in Ontario From 2011 to 2018. Clinical Breast Cancer. 20(5). e612–e617. 1 indexed citations

12.

Wang, Hanzhi, Lucas C. Mendez, Gerard Morton, et al.. (2020). Immune cell profiling in Gleason 9 prostate cancer patients treated with brachytherapy versus external beam radiotherapy: An exploratory study. Radiotherapy and Oncology. 155. 80–85. 7 indexed citations

13.

Olkhov‐Mitsel, Ekaterina, Anjelica Hodgson, Stanley K. Liu, et al.. (2020). Can immune markers help identify fast relapse in patients with muscle invasive bladder cancer?. Pathology - Research and Practice. 216(11). 153200–153200. 2 indexed citations

14.

Hodgson, Anjelica, Bas W.G. van Rhijn, Sung Sun Kim, et al.. (2020). Reassessment of p53 immunohistochemistry thresholds in invasive high grade bladder cancer shows a better correlation with TP53 and FGFR3 mutations. Pathology - Research and Practice. 216(11). 153186–153186. 13 indexed citations

15.

Drost, Leah, et al.. (2017). Papillary Carcinoma of the Male Breast: A Case Series. 1(1). 1 indexed citations

16.

Ganesh, Vithusha, Leah Drost, Justin Lee, et al.. (2017). A retrospective review of phyllodes tumours of the breast: A single institution experience. The Breast. 38. 52–57. 16 indexed citations

17.

Kershaw, Lucy, Linda G.W. Kerkmeijer, C.A. Lawton, et al.. (2016). MRI-guided prostate adaptive radiotherapy – A systematic review. Radiotherapy and Oncology. 119(3). 371–380. 117 indexed citations

18.

Huang, Xiaoyong, Samira Taeb, Sahar Jahangiri, et al.. (2013). miRNA-95 Mediates Radioresistance in Tumors by Targeting the Sphingolipid Phosphatase SGPP1. Cancer Research. 73(23). 6972–6986. 125 indexed citations

19.

Han, Kathy, Sharon Nofech‐Mozes, Steven A. Narod, et al.. (2011). Expression of HER2neu in Ductal Carcinoma in situ is Associated with Local Recurrence. Clinical Oncology. 24(3). 183–189. 43 indexed citations

20.

Vesprini, Danny, Robert K. Nam, John Trachtenberg, et al.. (2001). HPC2 Variants and Screen-Detected Prostate Cancer. The American Journal of Human Genetics. 68(4). 912–917. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact